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Asthma is a disease characterized by inflammation which affects both proximal and distal air-
ways. We evaluated the prevalence of small airway obstruction (SAO) in a group of clinically
stable asthmatics with both normal forced expiratory volume in the first second (FEV1) and
normal FEV1/forced vital capacity (FVC) and treated with an association of inhaled corticoste-
roids (ICSs) and long acting b2-agonists (LABAs). Clinical evaluation included the measurement
of dyspnea, asthma control test and drug compliance.
The prevalence of SAO was estimated by spirometry and plethysmography and defined by
the presence of one or more of the following criteria: functional residual capacity
(FRC) > 120% predicted (pred), residual volume (RV) > pred þ 1.64 residual standard deviation
(RSD), RV/total lung capacity (TLC) > pred þ 1.64 RSD, forced expiratory flow (FEF)25e75%
< pred  1.64 RSD, FEF50% < pred  1.64 RSD, slow vital capacity (SVC)  FVC > 10%.
Among the 441 patients who were included, 222 had normal FEV1 and FEV1/FVC. At least one
criteria of SAO was found in 115 (52%) mainly lung hyperinflation (39% based on high FRC, RV or
RV/TLC) and more rarely distal airflow limitation (15% based on FEF25e75% or FEF50%) or expira-
tory trapping (10% based on increased SVC  FVC). In the patients with only SAO (no PAO), there0, Hoˆpital Foch, Universite´ Versailles Saint-Quentin, 11 rue Guillaume Lenoir, 92150 Suresnes, France.
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1668 T. Perez et al.was no relationship between SAO, asthma history and the scores of dyspnea, asthma control or
drug compliance.
These results suggest that in asthmatics with normal FEV1 and FEV1/FVC, treated with ICSs
and LABAs, SAO is found in more than half of the patients indicating that the routinely used lung
function tests can underestimate dysfunctions occurring in the small airways.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Asthma is characterized by a chronic inflammatory process
which affects the whole respiratory tract, from central to
peripheral airways, and the site of this involvement de-
termines the resulting pathophysiology of the disease. The
peripheral airways, commonly defined as small airways, are
those with less than 2 mm in internal diameter and may
account for up to 50e90% of total airflow resistance in
asthmatics [1]. However, studies of distal airways have
proven difficult likely explaining why their role in the
natural history of asthma has been neglected for a long
time.
Spirometry and plethysmography are the most widely
available noninvasive pulmonary function tests (PFTs) to
assess distal airway impairment. During the forced expira-
tory maneuver, the volume of air expired in the first second
of a forced expiration, known as FEV1 reflects mostly the
proximal airway assessment, whereas distal airways
contribute mainly to the second part of expiration [2]. An
obstruction in distal airways causes a slowing of expiratory
flows in the terminal portion of the spirogram and a
concave shape on the flow-volume curve. Accordingly, the
forced expiratory flow (FEF) between 25% and 75% of forced
vital capacity (FEF25e75%) and FEF50% have been regarded as
a more sensitive measure of small airways narrowing than
FEV1. Unfortunately FEF25e75% has a broad range of
normality, is less reproducible than FEV1, and is difficult to
interpret if the forced vital capacity (FVC) is reduced or
increased [3].
A characteristic of small airway obstruction includes
premature airway closure and air trapping [4]. In this re-
gard, Sorkness et al. [3] have partitioned airway obstruc-
tion into components of air trapping (indicated by a
reduced FVC) and airflow limitation (indicated by FEV1/
FVC). Severe asthma was associated with prominent air
trapping whereas non severe asthma did not exhibit air
trapping, even at FEV1/FVC < 75% predicted. Air trapping
was further confirmed with measures of residual lung vol-
ume (RV)/total lung capacity (TLC) [3]. An increase in RV
and RV/TLC represents a marker of hyperinflation and air
trapping, and this pattern has been proposed as an early
detector of peripheral airways disease [5]; the ratio of FVC
to slow vital capacity (SVC) has also been suggested to be
an indirect marker of distal airway abnormalities, reflecting
either distal airway obstruction or loss of elastic recoil in
the parenchyma [6].
In addition, ventilation heterogeneity is a sensitive
marker of abnormal small airway function which can be
measured by using the single-breath washout [7] or
multiple-breath washout techniques [8e12]. Althoughnitrogen multiple-breath washout appears an appealing
technique for measurement of distal airway abnormalities,
the lack of standardization precludes its use in clinical
routine [13].
The first aim of the study was to assess the prevalence
of small airway obstruction (SAO) in clinically stable
moderate-to-severe asthmatics without proximal airway
obstruction (PAO). SAO was assessed, with both spirometry
and plethysmography, based on the following parameters:
(1) functional residual capacity (FRC), RV, RV/TLC as
marker of lung hyperinflation;
(2) FEF25e75% and FEF50% to detect distal airflow limitation;
(3) the difference between SVC and FVC to detect expira-
tory air trapping.
The second aim of the study was to identify possible
relationships between SAO and asthma clinical history and
phenotypic characteristics such as age, gender, smoking
history, asthma control and compliance.Material and methods
In this cross-sectional study, chest physicians have been
randomly selected in a French national list and were
offered to participate by post-office mail followed by a
phone call. They had to include five consecutive patients
with clinically stable moderate-to-severe asthma treated
with an association of ICSs and LABAs and referred to the
chest physicians for PFTs. The main exclusion criteria were
a smoking history equivalent to 10 pack-years or in the
month prior to screening, an hospitalization or emergency
department visit for asthma, a clinically significant respi-
ratory tract infection or the need for systemic
corticosteroid.
After reading an information leaflet, patients gave their
consent for the use of the data for research purpose, then
spirometry and plethysmographic lung measurements were
conducted. According to the French law on observational
studies, the study was approved by the CNOM (Conseil na-
tional de l’Ordre des Me´decins).
PAO was defined as a FEV1 less than 80% of pred and a
FEV1/FVC < 0.7. SAO was defined by the presence of one or
more of the following criteria:
(i) FRC > 120% pred, based on the official statement of
the ERS [14],
(ii) RV > RV pred þ 1.64 residual standard deviation (RSD),
(iii) RV/TLC > pred þ 1.64 RSD,
(iv) FEF25e75% < pred  1.64 RSD,
Figure 1 Patients’ distribution.
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(vi) SVC  FVC > 10%.
In addition to demographic data, the following clinical
parameters were also collected: atopy, smoking history,
duration of asthma, current treatment for asthma, number
of severe exacerbations (courses of systemic steroids and/
or emergency care visits and/or hospitalizations) over last
year, compliance, level of dyspnea and asthma control.
Compliance with treatment was assessed using Girerd score
[15], developed for monitoring of antihypertensive treat-
ment and adapted for asthma therapy. Dyspnea was
assessed using the Medical Research Council (MRC)
breathlessness scale [16] ranging from stage 1 (not troubled
by breathlessness except on strenuous exercise) to stage 5
(too breathless to leave the house or breathless when
undressing). Asthma control was assessed with the Asthma
Control Test (ACT) [17] with values ranging from 5 (very
poor control) to 25 (total asthma control). All the data were
recorded by the physicians through a secured web-based
data base (INES) and controlled for coherence.
Based on a previous study on SAO prevalence in asthma
[18], the hypothesis was set at 50% and the number of pa-
tients required for a 5% precision of the estimate was about
500. The number of chest physicians was set at around 100
and 5 patients were required per investigator to perform
this prevalence study. Statistical analysis was performed on
the full population. Patient’s characteristics and pulmonary
function parameters were first compared using Pearson’s c2
test or Fisher’s exact test for qualitative variables and
Students’ t test for quantitative variables.
In patients with no proximal impairment, logistic
regression was used to model propensities of the presence
of a criteria of SAO (defined by a cutoff value); a robust
multiple regression model was also used to avoid discus-
sions on cutoff value selection. Canonical correlation, theTable 1 Pulmonary function tests in patients with and without
Patients with p
airway obstruc
FEV1 (% pred  SD) 64.3  38.1
FVC (% pred  SD) 79.1  43.7
FEV1/FVC % 67.7 (12.4)
FRC (% pred  SD) 120.3  69.6
FRC > 120% pred (%) 36.9
RV (% pred  SD) 132.5  58.7
RV > pred þ 1.64 RSD (%) 43.8
RV/TLC (% pred  SD) 128.0  32.5
RV/TLC > pred þ 1.64 RSD (%) 49.8
FEF25e75% (% pred  SD) 43.3  18.3
FEF25e75% < pred  1.64 RSD (%) 40.6
SVC  FVC (L)  SD 0.2  0.4
SVC  FVC > 10% 26.4
FEF: forced expiratory flow, FEV1: forced expiratory volume in 1 the
capacity, L: liter, N: number of patients, Pred: predicted, RV: residua
was defined as FEV1 < 80% pred and/or FEV1/FVC < 70% pred.multivariate extension of multiple regression was used
to globally determine if functional respiratory parameters
of SAO and clinical symptoms provided independent
information.proximal airway impairment.
roximal
tion, N Z 219
Patients without proximal
airway obstruction, N Z 222
97.7  24.8
101.6  25.6
81.0 (7.0)
108.7  32.8
25.6
121.7  53.9
30.8
110.0  32.8
23.5
78.3  25.9
12.3
0.1  0.4
9.9
first second, FRC: functional residual capacity, FVC: forced vital
l volume, TLC: total lung capacity. Proximal airways obstruction
1670 T. Perez et al.Results
Four hundred and forty one patients were eligible for the
study; patients were firstly classified as having or not PAO
and further patients without PAO where classified as having
or not SAO (Fig. 1). Less than 5% of the patients were
treated with an association of LABA and ICS delivering
extrafine particles. Regardless of the proximal airways
status, hyperinflation in the study population affects 75% of
the patients. Since the FEFs can only be interpreted when
FVC stands within the normal range, the prevalence of SAO
in patients with and without PAO was compared with
respect to the other criteria. Hyperinflation (high FRC, RV
or RV/TLC) was detected in 64% of the patients with PAO
instead of 39% in the patients without PAO (P < 0.001);
expiratory trapping (high SVC  FVC) was detected in 26%
and 10% of these patients (P < 0.001), respectively (Table
1).
The demography and clinical history of patients without
PAO are reported in Table 2. Among the 222 patients
without PAO, 115 (52%) had SAO according to at least one ofTable 2 Demography and clinical history of patients without p
Patient
airway
N Z 22
Age (years) Mean (SD) 43.7 (1
Sex, N (%) Male 92 (41.
Female 130 (58
BMI (kg/m2) Mean (SD) 24.9 (4
[Range] [17.3;
Smoking, N (%) Smoker 28 (12.
Ex-smoker 33 (14.
Never-smoker 161 (72
Atopy, N (%) No 61 (27.
Yes 161 (72
Comorbidities, N (%) Yes 77 (34.
Exacerbations (n)a Mean (SD) 1.2 (2.
[Range] [0.0; 2
Systemic steroid courses Na (%)
If yes number of courses
No 152 (68
Yes 70 (31.
Mean (SD) 1.8 (1.
[Range] [1.0; 1
Emergency care visits (n)a Mean (SD) 0.1 (0.
[Range] [0.0; 3
ICS dosage Low 96 (45.
Medium 81 (38.
High 35 (16.
ACT Mean (SD) 20.0 (4
[range] [6.0; 2
Dyspnea (MRC score > 1) N (%) 81 (37.
N: number of patients, SD: Standard deviation, BMI Z body mass ind
a Number in the previous year.the pre-specified criteria of either hyperinflation (high FRC,
RV or RV/TLC), impairment of mid-expiratory flows
(FEF25e75% or FEF50%), and/or expiratory trapping
(SVC  FVC) (Table 3). At least one criteria of lung hyper-
inflation was found in 39% of the patients without PAO,
distal airflow limitation in 15% and expiratory trapping in
10%.
An ACT score  20 was found in 39% of the patients
without PAO with no difference between the patients with
(39%) or without SAO (35%). There was no correlation either
between ACT score and the different parameters of SAO in
the whole population of 222 patients without PAO or be-
tween ACT score and the alteration of each parameter of
SAO in the corresponding subgroups of patients. Dyspnea
(MRC > 1) was present in 36% of the patients without PAO
with no difference between the patients with (35%) or
without SAO (38%). A weak compliance to the treatment
was observed in 21% of the patients with no difference
between patients with (21%) or without SAO (17%).
Neither univariate analysis (Table 4) nor canonical
regression showed a significant association between theroximal airway obstruction.
s without proximal
obstruction,
2
Small airway
obstruction,
N Z 115
No small airway
obstruction,
N Z 82
6.14) 44.4 (15.79) 43.6 (16.68)
4%) 50 (43.5%) 32 (39.0%)
.6%) 65 (56.5%) 50 (61.0%)
.43) 24.8 (4.3) 24.9 (4.43)
51.2] [17.3; 43.8] [17.8; 51.2]
6%) 10 (8.7%) 12 (14.6%)
9%) 17 (14.8%) 14 (17.1%)
.5%) 88 (76.5%) 56 (68.3%)
5%) 30 (26.1%) 24 (29.3%)
.5%) 85 (73.9%) 58 (70.7%)
7%) 37 (32.2%) 32 (39.0%)
27) 0.9 (1.65) 1.5 (3.06)
0.0] [0.0; 10.0] [0.0; 20.0]
.5%) 83 (72.2%) 54 (65.9%)
5%) 32 (27.8%) 28 (34.1%)
39)** 2.1 (1.86)** 1.4 (0.69)
0.0] [1.0; 10.0] [1.0; 3.0]
30) 0.1 (0.29) 0.0 (0.35)
.0] [0.0; 2.0] [0.0; 3.0]
3%) 44 (40.7%) 41 (51.9%)
2%) 42 (38.9%) 30 (38.0%)
5%) 22 (20.4%) 8 (10.1%)
.1) 20.1 (4.2) 20.3 (3.8)
5.0] [6.0; 25.0] [10.0; 25.0]
5%) 40 (34.8%) 31 (37.8%)
ex.
Table 3 Small airway obstruction in patients without proximal airway obstruction.
SAO, n Z 115 No SAO, n Z 82
N (%a) Value % (SD) Value % (SD)
Hyperinflation
FRC > 120% pred 45 (49.5%) 151 (34) 94 (15)
RV > pred þ 1.64 RSD 68 (59.1%) 174 (46) 93 (27)
RV/TLC > pred þ 1.64 RSD 52 (45.2%) 152 (26) 93 (22)
Airflow limitation
FEF25e75 < pred  1.64 RSD 27 (24.1%) 54 (11) 83 (22)
FEF50 < pred  1.64 RSD 17 (15.0%) 46 (11) 81 (23)
Expiratory trapping
SVC  FVC > 10% 21 (18.8%) 0.66 (0.37) 0.03 (0.25)
FRC: functional residual capacity, FVC: forced vital capacity, FEF: forced expiratory flow, N: number of patients, RSD: residual standard
deviation, RV: residual volume, SD: standard deviation, SVC: slow vital capacity, TLC: total lung capacity, SAO: small airway obstruction.
a % Without missing data.
Small airways in asthmatics 1671SAO criteria and the clinical variables as obtained from the
clinical questionnaire and patient history.
Discussion
The main finding of the present study is that more than half
of the clinically stable moderate-to-severe asthmatics
treated with the association of ICS and LABA and without
PAO have at least one validated criteria of SAO. In these
patients, SAO was mainly evidenced by plethysmographic
lung volumes (lung hyperinflation) rather than spirometry.
None of the clinical data concerning asthma character-
istics, including asthma control appeared to be associated
with SAO. More than half of the patients has either an
ACT > 20 or a MRC Z 1 and, of note, with rare occurrence
of exacerbations and nearly no emergency care visits. This
accords with the observations of Bourdin et al. [18] and
Veen et al. [19], both showing a relationship between
frequent (>2/y) exacerbations and higher degree of small
airways dysfunction. Furthermore, the accuracy of ACT in
identifying controlled patients according to GINA guidelines
is not optimal, due to its good sensitivity but poor speci-
ficity [20] and this may contribute to explain the lack of
relationship with SAO. In addition, the sensitivity of the
MRC scale may be insufficient in asthmatic patients with
moderate or intermittent dyspnea. Whether the presence
of SAO in patients without PAO may influence the long-term
outcome of asthma requires prospective studies comparing
patients with or without persistent SAO.
The accuracy of FEV1/FVC ratio in diagnosing airflow
obstruction remains controversial and abnormalities of
small airway function may not be readily detected using
routine pulmonary function testing. Wagner et al. [21] re-
ported an increase in peripheral airflow resistance of
several fold even in asymptomatic asthma subjects who
have normal FEV1.
The results of our survey are in line with the recent
article of Jain et al. [22] which concludes that a significant
proportion of asthmatic patients have elevated RV and
abnormal RV/TLC ratio in the presence of normal FEV1/
FVC. The results of our survey are also in agreement withthe recent observation of Pisi et al. [23] who showed that a
small airway involvement can be detected in asthmatic
patients with normal FEV1 values.
In a previous survey, an increase in RV over 120% of
predicted values or a decrease in inspiratory capacity more
than 10% was detected in about half of the asthmatic pa-
tients without PAO [21]. SAO was also more frequently
evidenced by plethysmographic lung volumes (lung hyper-
inflation) rather than spirometry (FEFs less than 50% pred).
Although the measurement of RV is an easy-to-perform
test, with good reproducibility and low intra-patient vari-
ability, it is commonly envisaged as a rough method of esti-
mating the function of small airways, mainly because it only
allows a volumetric characterization of premature airway
closure andair trapping, and is not able to detect less evident
functional changes of distal airways conductance and
ventilation patterns. In asthma, contrary to COPD, TLC is
usually within normal values [24], resulting in increased RV/
TLC. Mechanisms leading to lung hyperinflation in asthmatics
include expiratory airflow limitation and premature closure
of small airways [25], activity of inspiratory muscles at the
end of expiration and reduced pulmonary elasticity [26]. Our
study confirms that RV/TLC is a more sensitive index of lung
hyperinflation than an increase in FRC.
The FEF25e75% is easily available explaining likely that it
is one of the most popular indices of peripheral airways
obstruction, resembling the concavity of the flow-volume
curve [27]. However, its use in clinical practice is
hampered by physiological variability and measurement
inconsistency issues [3,28,29]. In addition, FEF25e75% can be
interpreted only when FVC stands within normal value
limits; what is more, this parameter appears of limited
reliability to assess distal airway function according to the
findings from the Severe Asthma Research Program of the
National Heart Lung and Blood Institute, which showed a
lack of correlation between FEF25e75% and indices of air
trapping [3]. Similarly, FEF50% was unable to predict hy-
perinflation in asthmatic children with mainly normal lung
function [30]. This criterion appears to represent central
airflow limitation rather than a peripheral airway disease as
stated in international PFT guidelines [29].
Table 4 Univariate logistic regression with SAO as dependent variable in the 222 patients without PAO.
N Eventa OR CI 95% p-Value Global p-value
Age 0.396
<48 years 137 66 e e e
48 years 85 49 1.29 [0.72; 2.30] 0.396
Sex 0.532
Male 92 50 e e e
Female 130 65 0.83 [0.47; 1.48] 0.532
Smoking status 0.353
Smoker 28 10 e e e
Past-smoker 33 17 1.89 [0.76; 4.65] 0.169
Non-smoker 161 88 1.46 [0.49; 4.37] 0.501
Atopy 0.622
No 61 30 e e e
Yes 161 85 1.17 [0.62; 2.21] 0.622
Comorbidity 0.321
No 145 78 e e e
Yes 77 37 0.74 [0.41; 1.34] 0.321
Number of exacerbations 197 115 0.89 [0.78; 1.03] 0.109 0.109
Number of admissions in emergencies 197 115 1.25 [0.48; 3.29] 0.649 0.649
Number of hospital stays 197 115 0.58 [0.12; 2.74] 0.491 0.491
Oral steroids courses in continuous 0.343
No 152 83 e e e
Yes 70 32 0.74 [0.40; 1.37] 0.343
Observance score 0.632
Good observant 66 37 e e e
Minor non-observant 109 54 1.11 [0.48; 2.56] 0.803
Non-observant 47 24 0.80 [0.42; 1.52] 0.492
MRC scale 0.881
Stage 1 141 75 e e e
Stage 2 69 34 1.02 [0.27; 3.80] 0.976
Stage 3/4/5 12 6 0.86 [0.46; 1.59] 0.623
Asthma control test 0.591
<20 87 45 e e e
20 135 70 0.85 [0.47; 1.53] 0.591
CI: confidence interval, SAO: small airway obstruction, N: number of patients, OR: odds ratio.
a : eventZPatient with SAO.
1672 T. Perez et al.Difference in SVC and FVC is a potential and rather
simple indicator of airway collapse during forced expiration
(expiratory trapping). This may indirectly suggest SAO
impairment or a loss of elastic recoil although it has not yet
received a large scale validation in severe asthmatic pa-
tients [6]. In the present study, expiratory trapping was less
frequent in both patients with or without PAO than the
other criteria of SAO.
Busacker et al. [30] showed that, in severe asthma, air
trappers were significantly more likely to be atopic, to have
a history of asthma-related hospitalizations, intensive care
unit visits, and/or mechanical ventilation compared to
subjects classified as non-trappers. Air trapping was how-
ever assessed by CT in this study. Hyperinflation was also
shown to correlate with distal eosinophilic inflammation on
transbronchial biopsies in severe asthmatic adults [31].There are very few studies on the prevalence and clin-
ical relevance of hyperinflation in adult asthma. In chil-
dren, a significant hyperinflation was found in 40% of cases
and these patients had more symptoms of asthma [32]. In
addition, a significant hyperinflation can be detected in 11%
of patients without PAO [33]. Prevalence of hyperinflation
thus appears higher in our sample of asthmatic adults
without PAO.
Albeit data in children are not always applicable to
adults, recent studies using impulse oscillometry showed a
significant relationship between asthma control in children
and parameters of SAO, particularly low frequency reac-
tance and resistance [34,35]; the relationships between
these parameters and hyperinflation were however not
assessed. Using a highly sensitive nitrogen washout tech-
nique, Farah et al. [12] also demonstrated a significant
Small airways in asthmatics 1673relationship between the changes in asthma control and
parameters of ventilation heterogeneity evaluating small
airways.
Furthermore, impulse oscillometry parameters reflect-
ing small airways impairment were found to correlate with
dyspnea, asthma control and health related quality of life
in clinically stable asthmatics [36], however no information
on proximal airway obstruction was provided.
In conclusion, our study shows that in a population of
clinically stable moderate to severe asthma receiving ICS
and LABA, with normal FEV1 and normal FEV1/FVC, SAO is
detectable in approximately 50% of patients mainly by the
use of plethysmography. In the present population of
mostly well-controlled asthmatics, patients with SAO were
not clinically distinguishable from patients without SAO.
Whether the presence of SAO may influence the long-term
outcome of asthma requires prospective studies
comparing patients with or without persistent SAO.Conflict of interest
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